Both drugs are concentrated in genital secretions as compared to plasma which is desirable for a pre-exposure prophylaxis (PrEP) agent. The signature mutations for TDF resistance are K65R and K70E ...
Ryan Bitton, PharmD, MBA, provides a payer perspective on the importance of creating future health policies for HIV PrEP agents using real-world evidence and considering the total cost of care for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results